Top

Osteoporosis International

Published in:

Open Access 01-11-2011 | Original Article

Seasonal variation of serum 25-hydroxyvitamin D levels in adult patients with inflammatory bowel disease

Authors: P. H. A. Bours, J. P. M. Wielders, J. R. Vermeijden, A. van de Wiel

Published in: Osteoporosis International | Issue 11/2011

Abstract

Summary

Patients with inflammatory bowel disease (IBD) are at risk of osteoporosis. Vitamin D (vitD) deficiency is known as a risk factor of osteoporosis. We observed low vitD blood levels in adult IBD patients both at the end of summer and winter. Furthermore, effects of oral vitD supplementation in (generally low) daily dosages were poor.

Introduction

Patients with IBD are at risk of osteoporosis. This study evaluates seasonal vitD status, determinants of vitD deficiency and effects of vitD supplementation in adult IBD patients.

Methods

Patients were screened for vitD deficiency at the end of summer and winter using serum 25OHD₃ (cut-off point, <50 nmol/L) combined with routine laboratory tests. A standardized questionnaire was used for demographic/lifestyle data i.e. IBD activity, health behaviour and vitD intake through diet and ultraviolet light.

Results

Late-summer, 39% of the included 316 patients were vitD deficient. Late-winter, 57% of the follow-up patients (n = 281) were deficient. Independent protective determinants of vitD deficiency were oral vitD supplementation (summer/winter: odds ratio [OR], 0.52 [95% confidence interval [CI], 0.29–0.94]/OR, 0.44 [95% CI, 0.26–0.75]), recent sun holiday (summer: OR, 0.42 [95% CI, 0.24–0.74]) and regular solarium visits (summer/winter: OR, 0.28 [95% CI, 0.13–0.63]/OR, 0.17 [0.06–0.50]). IBD activity (p = 0.031), red blood cell distribution width (RDW; p = 0.04) and erythrocyte sedimentation rate (p = 0.03) were associated with low vitD levels using univariate analyses of the extreme 25OHD quartiles. In a subgroup with vitD supplementation, still 30% (late-summer) and 44% (late-winter) were vitD deficient.

Conclusion

VitD deficiency is common in IBD patients, but prevalence might be comparable with the general population. Ultraviolet light is essential for adequate vitD levels. Effects of oral vitD supplementation in (generally low) daily dosages are poor. Determinants for low vitD levels were IBD activity and elevated inflammatory markers, suggesting that increased risk of osteoporosis in IBD might be more related to the inflammation than to vitD deficiency.

Vestergaard P (2004) Prevalence and pathogenesis of osteoporosis in patients with inflammatory bowel disease. Minerva Med 95:469–480PubMed

Schoon EJ, van Nunen AB, Wouters RS, Stockbrugger RW, Russel MG (2000) Osteopenia and osteoporosis in Crohn’s disease: prevalence in a Dutch population-based cohort. Scand J Gastroenterol Suppl 232:43–47PubMed

Ali T, Lam D, Bronze MS, Humphrey MB (2009) Osteoporosis in inflammatory bowel disease. Am J Med 122:599–604. doi:10.1016/j.amjmed.2009.01.022 PubMedCrossRef

Bernstein CN, Leslie WD (2004) Review article: osteoporosis and inflammatory bowel disease. Aliment Pharmacol Ther 19:941–952. doi:10.1111/j.1365-2036.2004.01876.x PubMedCrossRef

Holick MF (2007) Optimal vitamin D status for the prevention and treatment of osteoporosis. Drugs Aging 24:1017–1029PubMedCrossRef

Jahnsen J, Falch JA, Mowinckel P, Aadland E (2002) Vitamin D status, parathyroid hormone and bone mineral density in patients with inflammatory bowel disease. Scand J Gastroenterol 37:192–199PubMedCrossRef

Pappa HM, Gordon CM, Saslowsky TM, Zholudev A, Horr B, Shih MC, Grand RJ (2006) Vitamin D status in children and young adults with inflammatory bowel disease. Pediatrics 118:1950–1961. doi:10.1542/peds.2006-0841 PubMedCrossRef

Souza HN, Lora FL, Kulak CA, Manas NC, Amarante HM, Borba VZ (2008) Low levels of 25-hydroxyvitamin D (25OHD) in patients with inflammatory bowel disease and its correlation with bone mineral density. Arq Bras Endocrinol Metabol 52:684–691PubMedCrossRef

Sentongo TA, Semaeo EJ, Stettler N, Piccoli DA, Stallings VA, Zemel BS (2002) Vitamin D status in children, adolescents, and young adults with Crohn disease. Am J Clin Nutr 76:1077–1081PubMed

10.

Kuwabara A, Tanaka K, Tsugawa N, Nakase H, Tsuji H, Shide K, Kamao M, Chiba T, Inagaki N, Okano T, Kido S (2009) High prevalence of vitamin K and D deficiency and decreased BMD in inflammatory bowel disease. Osteoporos Int 20:935–942PubMedCrossRef

11.

Lennard-Jones JE (1989) Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 170:2–6, discussion 16–19PubMedCrossRef

12.

Wendel-Vos GC, Schuit AJ, Saris WH, Kromhout D (2003) Reproducibility and relative validity of the short questionnaire to assess health-enhancing physical activity. J Clin Epidemiol 56:1163–1169PubMedCrossRef

13.

Clara I, Lix LM, Walker JR, Graff LA, Miller N, Rogala L, Rawsthorne P, Bernstein CN (2009) The Manitoba IBD index: evidence for a new and simple indicator of IBD activity. Am J Gastroenterol 104:1754–1763. doi:10.1038/ajg.2009.197 PubMedCrossRef

14.

McCarthy D, Duggan P, O’Brien M, Kiely M, McCarthy J, Shanahan F, Cashman KD (2005) Seasonality of vitamin D status and bone turnover in patients with Crohn’s disease. Aliment Pharmacol Ther 21:1073–1083. doi:10.1111/j.1365-2036.2005.02446.x PubMedCrossRef

15.

Bischoff-Ferrari HA (2008) Optimal serum 25-hydroxyvitamin D levels for multiple health outcomes. Adv Exp Med Biol 624:55–71. doi:10.1007/978-0-387-77574-6_5 PubMedCrossRef

16.

Holick MF (2008) The vitamin D deficiency pandemic and consequences for nonskeletal health: mechanisms of action. Mol Aspects Med 29:361–368. doi:10.1016/j.mam.2008.08.008 PubMedCrossRef

17.

Gezondheidsraad (2008) Naar een toereikende inname van vitamine D. Den Haag: Gezondheidsraad “ISBN 978-90-5549-729-4”

18.

Hintzpeter B, Mensink GB, Thierfelder W, Muller MJ, Scheidt-Nave C (2008) Vitamin D status and health correlates among German adults. Eur J Clin Nutr 62:1079–1089. doi:10.1038/sj.ejcn.1602825 PubMedCrossRef

19.

Hypponen E, Power C (2007) Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors. Am J Clin Nutr 85:860–868PubMed

20.

Holick MF (2004) Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 80:1678S–1688SPubMed

21.

Vieth R (ed) (2005) The pharmacology of vitamin D, including fortification strategies. Elsevier, Amsterdam

22.

Holick MF (2007) Vitamin D deficiency. N Engl J Med 357:266–281. doi:10.1056/NEJMra070553 PubMedCrossRef

23.

Grimnes G, Almas B, Eggen AE, Emaus N, Figenschau Y, Hopstock L, Hutchinson M, Methlie P, Mihailova A, Sneve M, Torjesen P, Wilsgaard T, Jorde R (2010) Effect of smoking on the serum levels of 25-hydroxyvitamin D depends on the assay employed. Eur J Endocrinol. doi:10.1530/EJE-10-0150

24.

Melamed ML, Michos ED, Post W, Astor B (2008) 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 168:1629–1637. doi:10.1001/archinte.168.15.1629 PubMedCrossRef

25.

Jorgensen SP, Agnholt J, Glerup H, Lyhne S, Villadsen GE, Hvas CL, Bartels LE, Kelsen J, Christensen LA, Dahlerup JF (2010) Clinical trial: vitamin D3 treatment in Crohn’s disease—a randomized double-blind placebo-controlled study. Aliment Pharmacol Ther 32:377–383. doi:10.1111/j.1365-2036.2010.04355.x PubMedCrossRef

26.

Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, Orav JE, Stuck AE, Theiler R, Wong JB, Egli A, Kiel DP, Henschkowski J (2009) Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ 339:b3692. doi:10.1136/bmj.b3692 PubMedCrossRef

27.

Sanders KM, Stuart AL, Williamson EJ, Simpson JA, Kotowicz MA, Young D, Nicholson GC (2010) Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA 303:1815–1822. doi:10.1001/jama.2010.594 PubMedCrossRef

28.

Broe KE, Chen TC, Weinberg J, Bischoff-Ferrari HA, Holick MF, Kiel DP (2007) A higher dose of vitamin d reduces the risk of falls in nursing home residents: a randomized, multiple-dose study. J Am Geriatr Soc 55:234–239. doi:10.1111/j.1532-5415.2007.01048.x PubMedCrossRef

29.

Bischoff-Ferrari HA, Staehelin HB (2008) Importance of vitamin D and calcium at older age. Int J Vitam Nutr Res 78:286–292. doi:10.1024/0300-9831.78.6.286 PubMedCrossRef

30.

Leidig-Bruckner G, Roth HJ, Bruckner T, Lorenz A, Raue F, Frank-Raue K (2010) Are commonly recommended dosages for vitamin D supplementation too low? Vitamin D status and effects of supplementation on serum 25-hydroxyvitamin D levels-an observational study during clinical practice conditions. Osteoporos Int. doi:10.1007/s00198-010-1214-5 PubMed

31.

Bischoff-Ferrari HA, Shao A, Dawson-Hughes B, Hathcock J, Giovannucci E, Willett WC (2009) Benefit-risk assessment of vitamin D supplementation. Osteoporos Int. doi:10.1007/s00198-009-1119-3 PubMed

32.

Clarke K, Sagunarthy R, Kansal S (2008) RDW as an additional marker in inflammatory bowel disease/undifferentiated colitis. Dig Dis Sci 53:2521–2523. doi:10.1007/s10620-007-0176-8 PubMedCrossRef

33.

Lippi G, Targher G, Montagnana M, Salvagno GL, Zoppini G, Guidi GC (2009) Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients. Arch Pathol Lab Med 133:628–632PubMed

34.

Froicu M, Weaver V, Wynn TA, McDowell MA, Welsh JE, Cantorna MT (2003) A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol Endocrinol 17:2386–2392. doi:10.1210/me.2003-0281 PubMedCrossRef

35.

Forman JP, Curhan GC, Taylor EN (2008) Plasma 25-hydroxyvitamin D levels and risk of incident hypertension among young women. Hypertension 52:828–832. doi:10.1161/HYPERTENSIONAHA.108.117630 PubMedCrossRef

36.

Giovannucci E (2009) Vitamin D and cardiovascular disease. Curr Atheroscler Rep 11:456–461PubMedCrossRef

37.

Garland CF, Gorham ED, Mohr SB, Grant WB, Giovannucci EL, Lipkin M, Newmark H, Holick MF, Garland FC (2007) Vitamin D and prevention of breast cancer: pooled analysis. J Steroid Biochem Mol Biol 103:708–711. doi:10.1016/j.jsbmb.2006.12.007 PubMedCrossRef

38.

Gouni-Berthold I, Krone W, Berthold HK (2009) Vitamin D and cardiovascular disease. Curr Vasc Pharmacol 7:414–422PubMedCrossRef

39.

Cantorna MT, Zhu Y, Froicu M, Wittke A (2004) Vitamin D status, 1, 25-dihydroxyvitamin D3, and the immune system. Am J Clin Nutr 80:1717S–1720SPubMed

40.

Joseph AJ, George B, Pulimood AB, Seshadri MS, Chacko A (2009) 25 (OH) vitamin D level in Crohn’s disease: association with sun exposure & disease activity. Indian J Med Res 130:133–137PubMed

41.

Lagishetty V, Misharin AV, Liu NQ, Lisse TS, Chun RF, Ouyang Y, McLachlan SM, Adams JS, Hewison M (2010) Vitamin D deficiency in mice impairs colonic antibacterial activity and predisposes to colitis. Endocrinology 151:2423–2432. doi:10.1210/en.2010-0089 PubMedCrossRef

42.

Peyrin-Biroulet L, Oussalah A, Bigard MA (2009) Crohn’s disease: the hot hypothesis. Med Hypotheses 73:94–96. doi:10.1016/j.mehy.2009.01.022 PubMedCrossRef

43.

Wu S, Liao AP, Xia Y, Li YC, Li JD, Sartor RB, Sun J (2010) Vitamin D receptor negatively regulates bacterial-stimulated NF-κB activity in intestine. Am J Pathol. doi:10.2353/ajpath.2010.090998

44.

Miheller P, Muzes G, Hritz I, Lakatos G, Pregun I, Laszlo Lakatos P, Herszenyi L, Tulassay Z (2009) Comparison of the effects of 1,25 dihydroxyvitamin D and 25 hydroxyvitamin D on bone pathology and disease activity in Crohn’s disease patients. Inflamm Bowel Dis. doi:10.1002/ibd.20947

45.

Tilg H, Moschen AR, Kaser A, Pines A, Dotan I (2008) Gut, inflammation and osteoporosis: basic and clinical concepts. Gut 57:684–694. doi:10.1136/gut.2006.117382 PubMedCrossRef

46.

Imaz I, Zegarra P, Gonzalez-Enriquez J, Rubio B, Alcazar R, Amate JM (2009) Poor bisphosphonate adherence for treatment of osteoporosis increases fracture risk: systematic review and meta-analysis. Osteoporos Int. doi:10.1007/s00198-009-1134-4 PubMed

47.

Christakos S, Ajibade DV, Dhawan P, Fechner AJ, Mady LJ (2010) Vitamin D: metabolism. Endocrinol Metab Clin North Am 39:243–253. doi:10.1016/j.ecl.2010.02.002, table of contentsPubMedCrossRef

Title: Seasonal variation of serum 25-hydroxyvitamin D levels in adult patients with inflammatory bowel disease
Authors: P. H. A. Bours
J. P. M. Wielders
J. R. Vermeijden
A. van de Wiel
Publication date: 01-11-2011
Publisher: Springer-Verlag
Published in: Osteoporosis International / Issue 11/2011
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-010-1484-y

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Seasonal variation of serum 25-hydroxyvitamin D levels in adult patients with inflammatory bowel disease

Abstract

Summary

Introduction

Methods

Results

Conclusion

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Summary

Introduction

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 11/2011

Bone remodeling around stable uncemented titanium stems during the second decade after total hip arthroplasty: a DXA study at 12 and 17 years

Bone mineral density enhances use of clinical risk factors in predicting ten-year risk of osteoporotic fractures in Chinese men: the Hong Kong Osteoporosis Study

Bone health in healthy Indian population aged 50 years and above

The association between serum osteocalcin levels and metabolic syndrome in Koreans

Effectiveness of interventions to improve the detection and treatment of osteoporosis in primary care settings: a systematic review and meta-analysis

Effect of different dress style on vitamin D level in healthy young Orthodox and ultra-Orthodox students in Israel